Cargando…

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

OBJECTIVE: To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS). METHODS: We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leurs, CE, Twaalfhoven, HAM, Lissenberg-Witte, BI, van Pesch, V, Dujmovic, I, Drulovic, J, Castellazzi, M, Bellini, T, Pugliatti, M, Kuhle, J, Villar, LM, Alvarez-Cermeño, JC, Alvarez-Lafuente, R, Hegen, H, Deisenhammer, F, Walchhofer, LM, Thouvenot, E, Comabella, M, Montalban, X, Vécsei, L, Rajda, C, Galimberti, D, Scarpini, E, Altintas, A, Rejdak, K, Frederiksen, JL, Pihl-Jensen, G, Jensen, PEH, Khalil, M, Voortman, MM, Fazekas, F, Saiz, A, La Puma, D, Vercammen, M, Vanopdenbosch, L, Uitdehaag, BMJ, Killestein, J, Bridel, C, Teunissen, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350201/ https://www.ncbi.nlm.nih.gov/pubmed/31066634 http://dx.doi.org/10.1177/1352458519845844

Ejemplares similares

Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis—The PaSiMS II study
por: Bsteh, Gabriel, et al.
Publicado: (2017)

Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2021)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2020)

The Use of Smartphone Keystroke Dynamics to Passively Monitor Upper Limb and Cognitive Function in Multiple Sclerosis: Longitudinal Analysis
por: Lam, Ka-Hoo, et al.
Publicado: (2022)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
por: Hegen, Harald, et al.
Publicado: (2022)

Disease activity following pregnancy-related discontinuation of natalizumab in MS
por: Kleerekooper, Iris, et al.
Publicado: (2017)

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects
por: Weeda, M.M., et al.
Publicado: (2019)

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
por: Leurs, Cyra E, et al.
Publicado: (2017)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review
por: Hegen, Harald, et al.
Publicado: (2019)

The Effect of Transdermal Delivery of Fentanyl on Activity in Growing Pigs
por: Malavasi, LM, et al.
Publicado: (2005)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
por: Leurs, Cyra E, et al.
Publicado: (2017)

Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis
por: Auer, Michael, et al.
Publicado: (2018)

Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial
por: Nedeljkovic, Una, et al.
Publicado: (2015)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, J.A., et al.
Publicado: (2019)

Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
por: Habek, Mario, et al.
Publicado: (2022)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

Performance validity in outpatients with multiple sclerosis and cognitive complaints
por: Nauta, IM, et al.
Publicado: (2021)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88)
por: Rodic, Sindi Z., et al.
Publicado: (2016)

Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi
por: Berek, Klaus, et al.
Publicado: (2020)

Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study
por: Castellazzi, Massimiliano, et al.
Publicado: (2023)

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Metabolomic signatures associated with disease severity in multiple sclerosis
por: Villoslada, Pablo, et al.
Publicado: (2017)

How to execute research projects in clinical practice in a large medium secure forensic psychiatric facility
por: Brandt-Christensn, A.M., et al.
Publicado: (2022)

Smoking is not associated with higher prevalence of JC virus in MS patients
por: Auer, Michael, et al.
Publicado: (2018)

SARS-CoV2 infection as a potential trigger for severe relapse in a patient with multiple sclerosis who stopped disease modifying treatment due to COVID-19 pandemic
por: Auer, Michael, et al.
Publicado: (2021)

Temporal changes in cortical microporosity during estrogen deficiency associated with perilacunar resorption and osteocyte apoptosis: A pilot study
por: Allison, H., et al.
Publicado: (2022)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

WCN23-0461 PATTERNS OF RECOVERY OF KIDNEY FUNCTION IN PATIENTS WITH COVID-19 AND ACUTE KIDNEY INJURY IN A REFERENCE CENTER IN MEXICO
por: REAL, F., et al.
Publicado: (2023)

Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients
por: Castellazzi, Massimiliano, et al.
Publicado: (2019)

Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
por: Ferri, Caterina, et al.
Publicado: (2023)

Patterns and Interfaces in Dissipative Dynamics
por: Pismen, L.M
Publicado: (2006)

Prolonged expression of MHC class I - peptide expression in bone marrow derived retrovirus transfected matured dendritic cells by continuous centrifugation in the presence of IL-4
por: Hettihewa, L.M.
Publicado: (2011)

I-48 The clinical characteristics and therapy for SARS
por: Guo, L.M.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dphk382ll60gjq9vhl0d8fs3ma